China Medical System Holdings Limited (FRA:2M7C)

Germany flag Germany · Delayed Price · Currency is EUR
1.140
+0.010 (0.88%)
Last updated: May 28, 2025
48.05%
Market Cap 2.89B
Revenue (ttm) 988.38M
Net Income (ttm) 214.35M
Shares Out n/a
EPS (ttm) 0.09
PE Ratio 13.47
Forward PE 14.55
Dividend 0.03 (2.92%)
Ex-Dividend Date Apr 28, 2025
Volume n/a
Average Volume 1,221
Open 1.130
Previous Close 1.130
Day's Range 1.130 - 1.140
52-Week Range 0.710 - 1.170
Beta n/a
RSI 68.71
Earnings Date May 15, 2025

About FRA:2M7C

China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China. The company offers cardio-cerebrovascular products include VELPHORO, a sucroferric oxyhydroxide chewable tablets and diazepam nasal spray for seizure clusters; XinHuoSu, a recombinant human brain natriuretic peptide for acute heart failure; Plendil, a felodipine sustained release tablets for hypertension; and Deanxit, a flupentixol and melitracen tablets for mild-to-moderate ... [Read more]

Industry Pharmaceutical Preparations
Founded 1995
Employees 6,141
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 2M7C
Full Company Profile

Financial Performance

In 2024, FRA:2M7C's revenue was 7.47 billion, a decrease of -6.79% compared to the previous year's 8.01 billion. Earnings were 1.62 billion, a decrease of -32.54%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.